MELA Sciences (MELA) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-2.45M
Depreciation and amortization	4.84M
Noncash compensation	401K
(Increase) decrease in prepaid expenses and other current assets	202K
Decrease in accounts payable and accrued expenses	-2.56M
Increase in other assets
Increase in deferred rent
Decrease in other current liabilities	-40K
Net cash used in operating activities
Purchases of property and equipment
Proceeds from sale of fixed assets
Net cash used in investing activities
Proceeds from exercise of stock options
Proceeds from exercise of stock warrants
Expenses related to public offering	0
Proceeds from Committed Equity Financing Facility
Expenses related to Committed Equity Financing Facility
Net cash provided by financing activities
Net decrease in cash and cash equivalents	-346K
Cash and cash equivalents at beginning of period	3.3M
Cash and cash equivalents at end of period	2.96M
Deferred financing costs charged to additional paid-in capital

Entities mentioned with MELA

View All Entities